Present results of the TACTIVE-N trial, a Phase 2 clinical trial of neoadjuvant vepdegestrant, in a mini oral session at European Society for Medical Oncology 2025 Congress (ClinicalTrials.gov ...

Trump administration terminates 22 mRNA vaccine contracts, shifting focus to safer alternatives, sparking controversy and ...

AI research is central to many of the deals. In April, French pharmaceutical giant Sanofi announced a $1.7 billion agreement ...

The Trump administration on Tuesday announced it would terminate 22 federal contracts for mRNA-based vaccines despite safety ...

US President Donald Trump's administration has announced it would terminate 22 federal contracts for mRNA-based vaccines, ...

President Donald Trump’s administration on Tuesday announced it would terminate 22 federal contracts for mRNA-based vaccines, ...

The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the ...

Palantir Technologies reported after the market closed yesterday and had another blowout quarter. Berkshire Hathaway was a ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...